Note: This section contains information in English only.
Thu, 06 Mar 2025 06:30:03 GMT
Source: Dukascopy Bank SA
Novo Nordisk will sell its weight-loss drug Wegovy for $499/month to cash-paying patients, following Eli Lilly's price cuts for its obesity drug Zepbound.
For further information regarding potential cooperation, please call us or make callback request.
To learn more about Dukascopy Bank Binary Options
/ Forex trading platform, SWFX and other trading related information, please call us or make callback request.
To learn more about Crypto Trading / CFD / Forex trading platform, SWFX and other trading related information, please call us or make callback request.
To learn more about Business Introducer and other trading related information, please call us or make callback request.
For further information regarding potential cooperation, please call us or make callback request.